Bioequivalence Analysis of Terazosin Hydrochloride Tablets Based on Parallel Artificial Membrane Permeability Analysis
Open Access
- 5 August 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (8) , 1024
Abstract
Parallel artificial membrane permeability analysis (PAMPA) is used to determine the permeability of compounds through concentrated negatively charged phospholipid bilayer barriers. We employed MacroFlux (a scaled-up version of PAMPA) to test the permeation rate of terazosin hydrochloride (TH) tablets and predict in vivo bioequivalence. The dissolution profiles and permeability of one reference formulation, and seven generic TH tablets, were compared. The dissolution profiles of these generic tablets were equivalent to that of the reference drug in four different media. However, the flux and the total permeated amount of some generic TH tablets were below the lower limit of the confidence interval of the original acceptance range in MacroFlux, which implied risk in the bioequivalence test in vivo. We further evaluated potential factors responsible for this discrepancy by µFlux, including active pharmaceutical ingredient (API) permeability and excipient prescriptions. The analysis showed that different properties of API were a main factor leading to biological inequivalence in the MacroFlux assay, while excipient prescriptions did not have an impact on bioequivalence risk. These data indicated that the flux assay may be a helpful as an auxiliary method for predicting bioequivalence of generic drugs and analyze the factors responsible for bioequivalence risk.Keywords
Funding Information
- National Science and Technology Major Projects for “Major New Drugs Innovation and Development” (2017ZX09101001, 2024HYZX04)
- State Drug Administration key laboratory project (2017ZX09101001, 2024HYZX04)
This publication has 14 references indexed in Scilit:
- Role of α1‐blockers in the current management of hypertensionThe Journal of Clinical Hypertension, 2022
- Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidatesEuropean Journal of Pharmaceutical Sciences, 2022
- Simple and fast LC-MS/MS method for quantification of terazosin in human plasma and application to bioequivalence studyJournal of Chromatography B, 2021
- Decision Science for Generic Drug Development and ReviewThe Journal of Clinical Pharmacology, 2019
- Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeabilityEuropean Journal of Pharmaceutical Sciences, 2019
- Generic Drugs: Expanding Possibilities for Clinical PharmacologyClinical Pharmacology & Therapeutics, 2019
- The effect of formulation additives on in vitro dissolution-absorption profile and in vivo bioavailability of telmisartan from brand and generic formulationsEuropean Journal of Pharmaceutical Sciences, 2018
- PAMPA—critical factors for better predictions of absorptionJournal of Pharmaceutical Sciences, 2007
- The Relationship between Terazosin Dose and Blood Pressure Response in Hypertensive PatientsThe Journal of Clinical Pharmacology, 2000
- Pharmacology of terazosinThe American Journal of Medicine, 1986